+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Avian Influenza Vaccines Market - Global Forecast 2026-2032- Product Image
Avian Influenza Vaccines Market - Global Forecast 2026-2032- Product Image
Sale

Avian Influenza Vaccines Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6128232
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Avian Influenza Vaccines Market is projected to reach USD 851.38 Million in 2026. It is expected to continue growing at a CAGR of 9.98%, reaching USD 1.51 Billion by 2032.

Avian Influenza Vaccines: Executive Summary and Strategic Context

Avian influenza vaccines are used within broader disease-control programs that also include surveillance, biosecurity, movement controls, testing, culling, and trade-management measures. Their role varies by poultry type, production system, regulatory framework, and the epidemiological profile of circulating viruses. Policy decisions increasingly balance animal-health protection, food-system continuity, public-health considerations, vaccine performance, and the need to preserve confidence in disease-status reporting.

Surveillance, Biosecurity, and Policy Are Reshaping Vaccine Use

The landscape is shifting from reactive outbreak response toward integrated preparedness. Authorities and producers are placing greater emphasis on risk-based surveillance, rapid diagnostics, compartmentalization, strengthened farm hygiene, controlled animal movement, and documented vaccination programs. International trade requirements and concerns about distinguishing infected from vaccinated animals are also influencing vaccine selection, monitoring protocols, and the conditions under which vaccination is permitted or expanded.

Artificial Intelligence Strengthens Detection, Risk Assessment, and Response Planning

Artificial intelligence can support avian influenza control by improving analysis of genomic, epidemiological, production, weather, and wildlife-movement data. Machine-learning systems may help prioritize surveillance locations, identify unusual mortality or production patterns, interpret diagnostic signals, and model transmission risks. These tools do not replace validated laboratory testing or veterinary judgment: their value depends on representative data, transparent validation, cybersecurity, interoperability, and clear accountability for decisions involving vaccination, movement, and trade.

Regional Insights: Diverse Regulatory and Epidemiological Priorities

North America is emphasizing coordinated surveillance, poultry-sector biosecurity, wildlife monitoring, and preparedness for incursions across commercial and backyard flocks. Latin America is balancing export-oriented poultry production with uneven veterinary infrastructure and the need to strengthen regional coordination. Europe is focused on harmonized animal-health rules, risk-based vaccination policies, wildlife-associated transmission, and maintaining trade confidence. The Middle East faces varied production systems, cross-border movement risks, and differing regulatory capacity. Africa’s priorities include accessible diagnostics, field surveillance, biosecurity, and support for smallholder and commercial producers. Asia-Pacific remains central to avian influenza prevention because of dense poultry populations, live-bird market exposure in some areas, migratory pathways, and substantial variation in national control programs.

Group Insights: Economic, Political, and Security Alliances Shape Coordination

ASEAN cooperation is particularly relevant to cross-border surveillance, live-animal movement, and harmonization of outbreak-response practices. BRICS members represent diverse poultry systems and regulatory environments, making information sharing, vaccine evaluation, and laboratory collaboration important areas of coordination. The European Union benefits from shared animal-health frameworks and coordinated risk management. G7 countries generally emphasize advanced surveillance, research collaboration, biosecurity, and food-system resilience. GCC members must account for import dependence, regional logistics, and high-value commercial production. NATO members may view animal-health preparedness through a broader resilience lens, including continuity of critical food and agricultural systems.

Country Insights: National Capacity Determines Implementation Priorities

Australia prioritizes biosecurity, surveillance, and protection from incursions affecting commercial and wildlife interfaces. Brazil focuses on safeguarding a major poultry sector through prevention, monitoring, and export-sensitive disease management. Canada emphasizes coordinated federal, provincial, producer, and wildlife surveillance. China combines large-scale poultry production with extensive disease-control and regulatory responsibilities. France, Germany, Italy, and Spain operate within European animal-health coordination while addressing domestic production, wildlife risks, and vaccination-policy requirements. India’s priorities include expanding surveillance and practical disease control across varied production systems. Japan and South Korea emphasize rapid detection, strict biosecurity, and preparedness for recurring regional risks. Mexico is focused on poultry protection, regulatory enforcement, and regional trade continuity. Russia manages geographically diverse production and surveillance challenges. The United Kingdom continues to prioritize layered prevention, outbreak response, and trade-sensitive disease-status management. The United States emphasizes surveillance, biosecurity, wildlife interfaces, and operational preparedness across diverse poultry sectors.

Action Priorities for Leaders: Integrate Vaccination With Measurable Disease Control

Industry leaders should treat vaccination as one component of a documented control system rather than a standalone intervention. Priorities include mapping exposure pathways, strengthening farm-level biosecurity, validating vaccine performance against relevant strains, maintaining traceable records, and aligning vaccination with surveillance that can detect infection and monitor field effectiveness. Organizations should also establish escalation protocols, train personnel, audit cold-chain and administration practices, and engage regulators and trading partners early. Investments in interoperable data systems and carefully governed analytical tools can improve response speed while preserving laboratory confirmation, animal-welfare standards, and transparent reporting.

Research Methodology: Evidence-Based Synthesis of Disease-Control Priorities

This executive summary uses the defined avian influenza vaccines market scope and organizes findings across global regions, economic and political groupings, and specified countries. The analysis is qualitative and focuses on documented themes in animal-health policy, surveillance, biosecurity, vaccination governance, trade requirements, production-system characteristics, and responsible use of artificial intelligence. It excludes market estimates, market sizing, forecasts, market shares, and company-specific analysis. Interpretations should be updated against current veterinary authority guidance, peer-reviewed evidence, laboratory findings, and applicable international standards.

Conclusion: Resilient Vaccination Programs Depend on Integrated Governance

The strategic importance of avian influenza vaccines is inseparable from surveillance quality, biosecurity execution, diagnostic capacity, regulatory clarity, and cooperation across borders. Regional and national conditions differ substantially, so effective programs require risk-based adaptation rather than a uniform model. Leaders can improve resilience by combining validated vaccination practices with transparent monitoring, strong data governance, coordinated preparedness, and continuous review of epidemiological evidence.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Avian Influenza Vaccines Market, by Vaccine Type
7.1. Introduction
7.2. Inactivated Vaccine
7.3. Live Attenuated Vaccine
7.4. Recombinant Vaccine
7.5. Subunit Vaccine
8. Avian Influenza Vaccines Market, by Animal Type
8.1. Introduction
8.2. Broiler Chickens
8.3. Layer Hens
8.4. Waterfowl
9. Avian Influenza Vaccines Market, by Application
9.1. Introduction
9.2. Preventive
9.2.1. Booster
9.2.2. Primary
9.3. Therapeutic
10. Avian Influenza Vaccines Market, by Administration Route
10.1. Introduction
10.2. Drinking Water
10.3. Intramuscular
10.4. Spray
10.5. Subcutaneous
11. Avian Influenza Vaccines Market, by Virus Strain
11.1. Introduction
11.2. H5N1
11.3. H7N9
11.4. H9N2
12. Avian Influenza Vaccines Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Avian Influenza Vaccines Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Avian Influenza Vaccines Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. AdvaCare Pharma Pte. Ltd.
16.2. AstraZeneca PLC
16.3. Bharat Biotech International Limited
16.4. BioNTech SE
16.5. Boehringer Ingelheim International GmbH
16.6. CAVAC S.A.
16.7. Ceva Santé Animale S.A.
16.8. Chengdu Tech-bank Biological Products Co., Ltd
16.9. CSL Limited
16.10. Daiichi Sankyo Company, Limited
16.11. Elanco Animal Health Incorporated
16.12. Emergent BioSolutions Inc.
16.13. Fatro S.P.A.
16.14. GlaxoSmithKline plc
16.15. Hester Biosciences Limited
16.16. HIPRA S.L.
16.17. Johnson & Johnson Private Limited
16.18. Medion S.A.
16.19. Merck & Co., Inc.
16.20. Mitsubishi Tanabe Pharma Corporation
16.21. Moderna, Inc.
16.22. Novavax, Inc.
16.23. Pfizer Inc.
16.24. Phibro Animal Health Corporation
16.25. QYH Biotech Company Limited
16.26. Sanofi S.A.
16.27. Seqirus UK Limited
16.28. Serum Institute of India Private Limited
16.29. Sinovac Biotech Ltd.
16.30. Vaxart, Inc.
16.31. Virbac S.A.
16.32. Zoetis Inc
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Avian Influenza Vaccines Market, Years Considered for the Study
FIGURE 2. Global Avian Influenza Vaccines Market, Research Design
FIGURE 3. Global Avian Influenza Vaccines Market, Research Framework
FIGURE 4. Global Avian Influenza Vaccines Market, Data Triangulation
FIGURE 5. Global Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Avian Influenza Vaccines Market Size, by Vaccine Type, 2025 vs 2032 (%)
FIGURE 7. Global Avian Influenza Vaccines Market Size, by Vaccine Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Avian Influenza Vaccines Market Size, by Animal Type, 2025 vs 2032 (%)
FIGURE 9. Global Avian Influenza Vaccines Market Size, by Animal Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Avian Influenza Vaccines Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Avian Influenza Vaccines Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Avian Influenza Vaccines Market Size, by Administration Route, 2025 vs 2032 (%)
FIGURE 13. Global Avian Influenza Vaccines Market Size, by Administration Route, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Avian Influenza Vaccines Market Size, by Virus Strain, 2025 vs 2032 (%)
FIGURE 15. Global Avian Influenza Vaccines Market Size, by Virus Strain, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Avian Influenza Vaccines Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Avian Influenza Vaccines Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Avian Influenza Vaccines Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Avian Influenza Vaccines Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Avian Influenza Vaccines Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Avian Influenza Vaccines Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Avian Influenza Vaccines Market Segmentation & Coverage
TABLE 2. Global Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
TABLE 3. Global Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 4. Global Inactivated Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Inactivated Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Inactivated Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Live Attenuated Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Live Attenuated Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Live Attenuated Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Recombinant Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Recombinant Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Recombinant Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Subunit Vaccine Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Subunit Vaccine Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Subunit Vaccine Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 17. Global Broiler Chickens Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Broiler Chickens Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Broiler Chickens Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Layer Hens Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Layer Hens Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Layer Hens Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Waterfowl Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Waterfowl Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Waterfowl Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 27. Global Preventive Market Size, by Region, 2017-2032 (USD Million)
TABLE 28. Global Preventive Market Size, by Group, 2017-2032 (USD Million)
TABLE 29. Global Preventive Market Size, by Country, 2017-2032 (USD Million)
TABLE 30. Global Booster Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global Booster Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global Booster Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global Primary Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Primary Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Primary Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Therapeutic Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Therapeutic Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Therapeutic Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 40. Global Drinking Water Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Drinking Water Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Drinking Water Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Spray Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Spray Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Spray Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 53. Global H5N1 Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global H5N1 Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global H5N1 Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global H7N9 Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global H7N9 Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global H7N9 Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global H9N2 Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global H9N2 Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global H9N2 Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Avian Influenza Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Avian Influenza Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 69. Asia-Pacific Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 70. North America Avian Influenza Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. North America Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 72. North America Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 73. North America Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 74. North America Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 75. North America Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 76. North America Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 77. Latin America Avian Influenza Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Latin America Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 79. Latin America Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 80. Latin America Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 81. Latin America Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 82. Latin America Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 83. Latin America Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 84. Europe Avian Influenza Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Europe Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 86. Europe Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 87. Europe Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 88. Europe Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 89. Europe Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 90. Europe Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 91. Middle East Avian Influenza Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Middle East Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 93. Middle East Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 94. Middle East Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 95. Middle East Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 96. Middle East Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 97. Middle East Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 98. Africa Avian Influenza Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Africa Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 100. Africa Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 101. Africa Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 102. Africa Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 103. Africa Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 104. Africa Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 105. Global Avian Influenza Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. ASEAN Avian Influenza Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. ASEAN Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 108. ASEAN Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 109. ASEAN Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 110. ASEAN Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 111. ASEAN Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 112. ASEAN Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 113. GCC Avian Influenza Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. GCC Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 115. GCC Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 116. GCC Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. GCC Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 118. GCC Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 119. GCC Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 120. European Union Avian Influenza Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. European Union Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 122. European Union Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 123. European Union Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 124. European Union Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 125. European Union Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 126. European Union Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 127. BRICS Avian Influenza Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. BRICS Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 129. BRICS Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 130. BRICS Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. BRICS Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 132. BRICS Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 133. BRICS Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 134. G7 Avian Influenza Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. G7 Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 136. G7 Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 137. G7 Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 138. G7 Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 139. G7 Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 140. G7 Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 141. NATO Avian Influenza Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 142. NATO Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 143. NATO Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 144. NATO Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 145. NATO Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 146. NATO Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 147. NATO Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 148. Global Avian Influenza Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 149. United States Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
TABLE 150. United States Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 151. United States Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 152. United States Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. United States Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 154. United States Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 155. United States Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 156. Canada Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
TABLE 157. Canada Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 158. Canada Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 159. Canada Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. Canada Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 161. Canada Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 162. Canada Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 163. Mexico Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
TABLE 164. Mexico Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 165. Mexico Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 166. Mexico Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 167. Mexico Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 168. Mexico Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 169. Mexico Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 170. Brazil Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
TABLE 171. Brazil Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 172. Brazil Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 173. Brazil Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 174. Brazil Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 175. Brazil Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 176. Brazil Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 177. United Kingdom Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
TABLE 178. United Kingdom Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 179. United Kingdom Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 180. United Kingdom Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 181. United Kingdom Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 182. United Kingdom Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 183. United Kingdom Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 184. Germany Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
TABLE 185. Germany Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 186. Germany Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 187. Germany Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. Germany Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 189. Germany Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 190. Germany Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 191. France Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
TABLE 192. France Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 193. France Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 194. France Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 195. France Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 196. France Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 197. France Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 198. Russia Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
TABLE 199. Russia Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 200. Russia Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 201. Russia Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. Russia Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 203. Russia Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 204. Russia Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 205. Italy Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
TABLE 206. Italy Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 207. Italy Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 208. Italy Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 209. Italy Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 210. Italy Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 211. Italy Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 212. Spain Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
TABLE 213. Spain Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 214. Spain Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 215. Spain Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. Spain Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 217. Spain Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 218. Spain Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 219. China Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
TABLE 220. China Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 221. China Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 222. China Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 223. China Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 224. China Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 225. China Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 226. India Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
TABLE 227. India Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 228. India Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 229. India Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. India Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 231. India Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 232. India Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 233. Japan Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
TABLE 234. Japan Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 235. Japan Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 236. Japan Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 237. Japan Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 238. Japan Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 239. Japan Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 240. Australia Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
TABLE 241. Australia Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 242. Australia Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 243. Australia Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. Australia Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 245. Australia Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 246. Australia Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 247. South Korea Avian Influenza Vaccines Market Size, 2017-2032 (USD Million)
TABLE 248. South Korea Avian Influenza Vaccines Market Size, by Vaccine Type, 2017-2032 (USD Million)
TABLE 249. South Korea Avian Influenza Vaccines Market Size, by Animal Type, 2017-2032 (USD Million)
TABLE 250. South Korea Avian Influenza Vaccines Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. South Korea Avian Influenza Vaccines Market Size, by Preventive, 2017-2032 (USD Million)
TABLE 252. South Korea Avian Influenza Vaccines Market Size, by Administration Route, 2017-2032 (USD Million)
TABLE 253. South Korea Avian Influenza Vaccines Market Size, by Virus Strain, 2017-2032 (USD Million)
TABLE 254. Global Avian Influenza Vaccines Market Share, by Key Player, 2025
TABLE 255. Global Avian Influenza Vaccines Market, Key Experts

Companies Mentioned

  • AdvaCare Pharma Pte. Ltd.
  • AstraZeneca PLC
  • Bharat Biotech International Limited
  • BioNTech SE
  • Boehringer Ingelheim International GmbH
  • CAVAC S.A.
  • Ceva Santé Animale S.A.
  • Chengdu Tech-bank Biological Products Co., Ltd
  • CSL Limited
  • Daiichi Sankyo Company, Limited
  • Elanco Animal Health Incorporated
  • Emergent BioSolutions Inc.
  • Fatro S.P.A.
  • GlaxoSmithKline plc
  • Hester Biosciences Limited
  • HIPRA S.L.
  • Johnson & Johnson Private Limited
  • Medion S.A.
  • Merck & Co., Inc.
  • Mitsubishi Tanabe Pharma Corporation
  • Moderna, Inc.
  • Novavax, Inc.
  • Pfizer Inc.
  • Phibro Animal Health Corporation
  • QYH Biotech Company Limited
  • Sanofi S.A.
  • Seqirus UK Limited
  • Serum Institute of India Private Limited
  • Sinovac Biotech Ltd.
  • Vaxart, Inc.
  • Virbac S.A.
  • Zoetis Inc

Related Topics

Related Reports

Avian Influenza Vaccine Market - Global Strategic Business Report - Product Image

Avian Influenza Vaccine Market - Global Strategic Business Report

  • Report
  • 286 Pages
  • Global
From
Veterinary Vaccines Market - Global Forecast 2026-2032 - Product Image

Veterinary Vaccines Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Equine Rhinopneumonitis Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Equine Rhinopneumonitis Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Avian Influenza Vaccine Market in United States - Product Image

Avian Influenza Vaccine Market in United States

  • Report
  • 190 Pages
  • United States
From
Poultry Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Poultry Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 114 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.